| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4409358 | ADME | Cytotoxicity against human TZM-bl cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay | Homo sapiens | 17 | ALA4406854 | cell-based format | Scientific Literature | |
| 2. | ALA4409359 | Functional | Antiviral activity against HIV1 VB59 infected in human TZM-bl cells incubated for 48 hrs by bright Glo-luciferase reporter gene assay | Human immunodeficiency virus 1 | 17 | ALA4406854 | organism-based format | Scientific Literature | |
| 3. | ALA4409360 | Toxicity | Therapeutic index, ratio of CC50 for human TZM-bl cells to IC50 for antiviral activity against HIV1 VB59 infected in human TZM-bl cells | 9 | ALA4406854 | cell-based format | Scientific Literature | ||
| 4. | ALA4409361 | Functional | Antiviral activity against HIV1 UG070 infected in human TZM-bl cells incubated for 48 hrs by bright Glo-luciferase reporter gene assay | Human immunodeficiency virus 1 | 17 | ALA4406854 | organism-based format | Scientific Literature | |
| 5. | ALA4409362 | Toxicity | Therapeutic index, ratio of CC50 for human TZM-bl cells to IC50 for antiviral activity against HIV1 UG070 infected in human TZM-bl cells | 15 | ALA4406854 | cell-based format | Scientific Literature | ||
| 6. | ALA4409363 | Functional | Antiviral activity against HIV1 92/BR/018 infected in human TZM-bl cells incubated for 48 hrs by bright Glo-luciferase reporter gene assay | Human immunodeficiency virus 1 | 3 | ALA4406854 | organism-based format | Scientific Literature | |
| 7. | ALA4409364 | Toxicity | Therapeutic index, ratio of CC50 for human TZM-bl cells to IC50 for antiviral activity against HIV1 92/BR/018 infected in human TZM-bl cells | 3 | ALA4406854 | cell-based format | Scientific Literature | ||
| 8. | ALA4409365 | Functional | Antiviral activity against HIV1 N119 infected in human TZM-bl cells incubated for 48 hrs by bright Glo-luciferase reporter gene assay | Human immunodeficiency virus 1 | 3 | ALA4406854 | organism-based format | Scientific Literature | |
| 9. | ALA4409366 | Toxicity | Therapeutic index, ratio of CC50 for human TZM-bl cells to IC50 for antiviral activity against HIV1 N119 infected in human TZM-bl cells | 3 | ALA4406854 | cell-based format | Scientific Literature | ||
| 10. | ALA4409367 | ADME | Cytotoxicity against human PBMC cells assessed as reduction in cell viability incubated for 5 days by MTT assay | Homo sapiens | 3 | ALA4406854 | cell-based format | Scientific Literature | |
| 11. | ALA4409368 | Functional | Antiviral activity against HIV1 VB51 infected in human PBMC cells incubated for 5 days by bright Glo-luciferase reporter gene assay | Human immunodeficiency virus 1 | 3 | ALA4406854 | organism-based format | Scientific Literature | |
| 12. | ALA4409369 | Toxicity | Therapeutic index, ratio of CC50 for human PBMC cells to IC50 for antiviral activity against HIV1 VB51 infected in human TZM-bl cells | 3 | ALA4406854 | cell-based format | Scientific Literature | ||
| 13. | ALA4409370 | Functional | Antiviral activity against HIV1 NL4.3 infected in human TZM-bl cells measured upto 24 hrs by bright Glo-luciferase reporter gene assay | Human immunodeficiency virus 1 | 4 | ALA4406854 | organism-based format | Scientific Literature | |
| 14. | ALA4409371 | Functional | Potency index, ratio of IC50 of dextran sulfate to IC50 of compound for antiviral activity against HIV1 NL4.3 infected in human TZM-bl cells measured upto 24 hrs by bright Glo-luciferase reporter gene assay | Human immunodeficiency virus 1 | 1 | ALA4406854 | organism-based format | Scientific Literature | |
| 15. | ALA4409372 | Functional | Potency index, ratio of IC50 of AZT to IC50 of compound for antiviral activity against HIV1 NL4.3 infected in human TZM-bl cells measured upto 24 hrs by bright Glo-luciferase reporter gene assay | Human immunodeficiency virus 1 | 1 | ALA4406854 | organism-based format | Scientific Literature | |
| 16. | ALA4409373 | Functional | Potency index, ratio of IC50 of NVP to IC50 of compound for antiviral activity against HIV1 NL4.3 infected in human TZM-bl cells measured upto 24 hrs by bright Glo-luciferase reporter gene assay | Human immunodeficiency virus 1 | 1 | ALA4406854 | organism-based format | Scientific Literature | |
| 17. | ALA4409374 | Functional | Potency index, ratio of IC50 of Raltegravir to IC50 of compound for antiviral activity against HIV1 NL4.3 infected in human TZM-bl cells measured upto 24 hrs by bright Glo-luciferase reporter gene assay | Human immunodeficiency virus 1 | 1 | ALA4406854 | organism-based format | Scientific Literature | |
| 18. | ALA4409375 | Functional | Potency index, ratio of IC50 of Ritonavir to IC50 of compound for antiviral activity against HIV1 NL4.3 infected in human TZM-bl cells measured upto 24 hrs by bright Glo-luciferase reporter gene assay | Human immunodeficiency virus 1 | 1 | ALA4406854 | organism-based format | Scientific Literature | |
| 19. | ALA4409376 | Functional | Antiviral activity against HIV1 NL4.3 infected in human TZM-bl cells measured upto 3 hrs by bright Glo-luciferase reporter gene assay | Human immunodeficiency virus 1 | 1 | ALA4406854 | organism-based format | Scientific Literature | |
| 20. | ALA4409377 | Functional | Antiviral activity against HIV1 NL4.3 infected in human TZM-bl cells measured upto 10 hrs by bright Glo-luciferase reporter gene assay | Human immunodeficiency virus 1 | 1 | ALA4406854 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!